Aiping Zhou

1.5k total citations · 1 hit paper
78 papers, 996 citations indexed

About

Aiping Zhou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Aiping Zhou has authored 78 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 36 papers in Oncology and 33 papers in Surgery. Recurrent topics in Aiping Zhou's work include Gastric Cancer Management and Outcomes (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Renal cell carcinoma treatment (14 papers). Aiping Zhou is often cited by papers focused on Gastric Cancer Management and Outcomes (20 papers), Colorectal Cancer Treatments and Studies (17 papers) and Renal cell carcinoma treatment (14 papers). Aiping Zhou collaborates with scholars based in China, United States and Singapore. Aiping Zhou's co-authors include Jiyan Liu, Hong Luo, Yongkun Sun, Jianming Ying, Benkang Shi, Jinjing Ni, Wen Zhang, Jinwan Wang, Shuihua Lu and Cheng Fu and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Aiping Zhou

76 papers receiving 983 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Open-label, Multicenter, Phase II Study of RC48-ADC, a HER2-Targeting Antibody–Drug Conjugate, in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

2020 192 citations Jianming Ying, Aiping Zhou et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aiping Zhou China	16	465	349	290	245	127	78	996
Zaed Hamady United Kingdom	20	644 1.4×	499 1.4×	241 0.8×	199 0.8×	108 0.9×	48	1.2k
Yuwen Zhou China	15	405 0.9×	116 0.3×	194 0.7×	213 0.9×	107 0.8×	53	868
John R. Stroehlein United States	21	461 1.0×	395 1.1×	328 1.1×	346 1.4×	130 1.0×	60	1.3k
María Ortiz Spain	19	335 0.7×	175 0.5×	120 0.4×	648 2.6×	201 1.6×	59	1.2k
Ju Hyun Kim South Korea	20	242 0.5×	339 1.0×	202 0.7×	261 1.1×	603 4.7×	102	1.4k
Xueping Wang China	23	428 0.9×	213 0.6×	279 1.0×	353 1.4×	171 1.3×	83	1.3k
Tara C. Rubinas United States	13	231 0.5×	794 2.3×	152 0.5×	396 1.6×	101 0.8×	30	1.5k
Xuemin Chen China	18	291 0.6×	260 0.7×	212 0.7×	176 0.7×	191 1.5×	64	834
Megumu Fujihara Japan	17	204 0.4×	230 0.7×	155 0.5×	133 0.5×	285 2.2×	60	990
Lin-Yong Zhao China	17	261 0.6×	271 0.8×	406 1.4×	497 2.0×	46 0.4×	58	1.1k

Countries citing papers authored by Aiping Zhou

Since Specialization

Citations

This map shows the geographic impact of Aiping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiping Zhou more than expected).

Fields of papers citing papers by Aiping Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiping Zhou. The network helps show where Aiping Zhou may publish in the future.

Co-authorship network of co-authors of Aiping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Aiping Zhou. A scholar is included among the top collaborators of Aiping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiping Zhou. Aiping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hou, Guozhu, Xin Cheng, Yuanyuan Jiang, et al.. (2025). Comparison of Al18F-NOTA-FAPI-74 and 18F-FDG PET/CT in the Evaluation and Staging of Hepatobiliary Malignancies. Clinical Nuclear Medicine. 50(7). 612–622. 1 indexed citations

Zhou, Aiping, et al.. (2025). NK cell‐based immunotherapy for hepatocellular carcinoma: Challenges and opportunities. Scandinavian Journal of Immunology. 101(2). e13433–e13433. 1 indexed citations

Li, Fangfei, et al.. (2025). Urine Output as a Novel Predictor for In‐Hospital Mortality in Acute Pulmonary Embolism Patients: Training With the MIMIC Database and Validation With Independent Cohort. Cardiovascular Therapeutics. 2025(1). 7907049–7907049. 1 indexed citations

Xie, Yibin, Wen Zhang, Chunxia Du, et al.. (2024). Perioperative chemotherapy with docetaxel plus oxaliplatin and S-1 (DOS) versus oxaliplatin plus S-1 (SOX) for the treatment of locally advanced gastric or gastro-esophageal junction adenocarcinoma (MATCH): an open-label, randomized, phase 2 clinical trial. Gastric Cancer. 27(3). 571–579. 10 indexed citations

Chen, Xiuying, Haiyan Jiang, Aiping Zhou, et al.. (2024). Is early bilateral compression ultrasonography and D-dimer monitoring appropriately for prophylaxis and diagnosis of deep venous thrombosis after cesarean section women: a single-center observation study of Chinese Han population. BMC Pregnancy and Childbirth. 24(1). 181–181. 1 indexed citations

Zhou, Aiping, et al.. (2023). 1070 Epidemiology and Incidence of Pelvic Fractures. British journal of surgery. 110(Supplement_7). 1 indexed citations

Shang, Bingqing, Xingang Bi, Yan Song, et al.. (2023). Neutrophil extracellular traps in relationship to efficacy of systemic therapy for metastatic renal cell carcinoma. Cancer Medicine. 12(24). 21807–21819. 5 indexed citations

İmani, Saber, Aiping Zhou, Lailing Du, et al.. (2023). Combatting resistance: Understanding multi-drug resistant pathogens in intensive care units. Biomedicine & Pharmacotherapy. 167. 115564–115564. 38 indexed citations

Nan, Yabing, Qingyu Luo, Xiaowei Wu, et al.. (2022). DLGAP1-AS2–Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma. Cancer Research. 82(16). 2887–2903. 19 indexed citations

10.

Zhou, Aiping, Hao Chen, Yiqi Yu, et al.. (2022). 1207P Neoadjuvant PD-L1 inhibitor (socazolimab) plus chemotherapy in patients with locally advanced esophageal squamous cell carcinoma (ESCC): A multicenter, randomized, double-blind phase II study. Annals of Oncology. 33. S1101–S1101. 2 indexed citations

11.

Zhou, Aiping, et al.. (2022). Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study. BMC Cancer. 22(1). 253–253. 4 indexed citations

12.

Zhang, Weimin, Yulin Sun, Tielong Liu, et al.. (2022). 423P Fruquintinib plus sintilimab in refractory repair-proficient (pMMR)/microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Preliminary clinical results and biomarker analyses from a phase II study. Annals of Oncology. 33. S728–S728. 5 indexed citations

13.

Sun, Yongkun, Aiping Zhou, Wen Zhang, et al.. (2021). Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study). Hepatology International. 15(3). 621–629. 41 indexed citations

14.

Zhang, Wen, Yong Li, Liyan Xue, et al.. (2021). Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study. Cancer Management and Research. Volume 13. 2163–2170. 9 indexed citations

15.

Deng, Yanhong, Weidong Zhang, Aiping Zhou, et al.. (2020). 70MO Efficacy and safety of envafolimab (KN035) in advanced tumours with mismatch-repair deficiency. Annals of Oncology. 31. S1270–S1270. 4 indexed citations

16.

Zhang, Wen, Chunxia Du, Yongkun Sun, et al.. (2018). Nab-paclitaxel plus S-1 as first-line followed by S-1 maintenance for advanced pancreatic adenocarcinoma: a single-arm phase II trial. Cancer Chemotherapy and Pharmacology. 82(4). 655–660. 21 indexed citations

17.

Zhou, Aiping, et al.. (2017). Efficacy of Topical Compound Danxiong Granules for Treatment of Dermatologic Toxicities Induced by Targeted Anticancer Therapy: A Randomized, Double‐Blind, Placebo‐Controlled Trial. Evidence-based Complementary and Alternative Medicine. 2017(1). 3970601–3970601. 8 indexed citations

18.

Yang, Lin, Qiong Qin, Aiping Zhou, et al.. (2013). Dose-finding study on adjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer. Molecular and Clinical Oncology. 2(1). 93–98. 5 indexed citations

19.

Zhou, Aiping, et al.. (2009). Clinical study of sorafenib in the treatment of Chinese patients with metastatic renal cell carcinoma. Zhonghua miniao waike zazhi. 30(1). 10–14. 1 indexed citations

20.

Huang, Jie, Shun Zhang, Meiping Ding, Aiping Zhou, & Xiaofeng Zhang. (1998). Acute effects of carbofuran in workers of two pesticide plants.. PubMed. 89 Suppl 2. S105–11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact